SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Naturade (NRDC)--a turnaround

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: leigh aulper who wrote ()7/15/1998 11:24:00 AM
From: leigh aulper   of 17
 
Naturade to Introduce Innovative Chinese Herbal Remedies

PARAMOUNT, Calif., July 15 /PRNewswire/ -- Naturade, Inc.'s (OTC Bulletin Board: NRDC) recently appointed Chairman, Ronald Ahrens, and Chief Executive Officer, Bill Stewart, will announce the introduction of the company's new, innovative Chinese herbal medicines.

Naturade(TM) is introducing the Chinese Way(TM) product line, which are clearly differentiated products and will be available for shipment this fall to health-food retailers such as GNC, Wholefoods and Wild Oats.

The Chinese Way(TM) products contain herbs sourced in China and then manufactured in the United States under U.S. purity standards. Consumer testing of the idea, brand name and packaging has been very favorable. The four new natural products all contain Chinese botanicals. The products are: an immune boosting product, the active ingredient of which has had successful clinical trials in South America and Europe, is supported by a unique, natural, long chain polysaccharide adjuvant; a head and chest support product using a special blend of herbs recently developed by the Chinese; a non- stimulatory sinus product; and a soothing line of throat lozenges that contain a proven Chinese herb. "These are not just ordinary herbs, they're used widely in China where they are part of the public health-care system and often reimbursed by insurance companies," said CEO Bill Stewart. They were introduced to Naturade through their partner, Taishan Pharmaceuticals, which has entered into a joint venture agreement with China's Ministry of Health.

Mr. Ahrens is the immediate past CEO of Merck Consumer Healthcare, Inc., and was responsible for supervising the Johnson & Johnson Merck joint venture which successfully introduced Pepcid AC(TM), the leading OTC switch product acid blocker. Prior to joining Merck, Mr. Ahrens served as the president of Bristol Myers Products Division and Richardson Vicks Health Care Division where he was responsible for such brands as Nyquil(TM) and Oil of Olay(TM). Mr. Stewart is a 16 year Richardson Vicks veteran where he was Director of Sales, before becoming President of the Thompson's Minwax Company, where he directed the increase of sales of the company from under $40 million to over $180 million annually.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext